(^668) Pet therapy, 387–388Phencyclidine (PCP)Phenothiazines, 472–476PhotosensitivityPhenylbutylpiperadines, 477–480Phobias, 161–162Phosphorus, 382tPhysical abusewithdrawal from, 89tantidepressant-related, 442action of, 473adverse reactions and side effects of, 473–474contraindications and precautions for, 473examples of, 472tadult, 311route and dosage for, 474–476antipsychotic-related, 497action of, 478adverse reactions and side effects of, 478–479contraindications and precautions for, 478examples of, 477t–478tinteractions of, 479route and dosage for, 479–480intoxication with, 89tuse/abuse of, 85, 89tinteractions of, 474^ ●^ SUBJECT INDEX
2506_Subject Index_639-682.indd 668 2506 Subject Index 639 Physiological factorsPhysical activity, 379, 384Physical factors- 68 in abuse and neglect, 311–312in adjustment disorder, 237in anxiety disorders, 163in attention-defisymptomatology of, 312in autistic disorder, 20–21in bipolar disorder, 146in borderline personality disorder, 278–279in conduct disorder, 27in dissociative disorders, 192in dysthymic disorder, 127DSM-IV-TR classifichild, 310, 317–318in antisocial personality disorder, 295–296in impulse control disorders, 257in obesity, 221in psychological factors affecting medical condition, 265Internet references on, 318–319 2 .indd 668 cit/hyperactivity disorder, 26 cation of, 608 1 10/1/10 9:42:01 AM 0 / 1 / 10 9 : 42 : 01 AM
barré
(Barré)
#1